Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 421

1.

Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database.

MacFadden DR, Crystal E, Krahn AD, Mangat I, Healey JS, Dorian P, Birnie D, Simpson CS, Khaykin Y, Pinter A, Nanthakumar K, Calzavara AJ, Austin PC, Tu JV, Lee DS.

Ann Intern Med. 2012 Feb 7;156(3):195-203. doi: 10.7326/0003-4819-156-3-201202070-00007.

PMID:
22312139
2.

Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.

Krahn AD, Lee DS, Birnie D, Healey JS, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen Z, Hardy J, Tu JV; Ontario ICD Database Investigators.

Circ Arrhythm Electrophysiol. 2011 Apr;4(2):136-42. doi: 10.1161/CIRCEP.110.959791. Epub 2011 Feb 15.

3.

Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database.

Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen Z, Hardy J, Tu JV; Investigators of the Ontario ICD Database.

J Am Coll Cardiol. 2010 Feb 23;55(8):774-82. doi: 10.1016/j.jacc.2009.11.029.

4.

Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.

Amit G, Suleiman M, Konstantino Y, Luria D, Kazatsker M, Chetboun I, Haim M, Gavrielov-Yusim N, Goldenberg I, Glikson M; Israeli Working Group on Pacing and Electrophysiology.

Europace. 2014 Aug;16(8):1175-80. doi: 10.1093/europace/euu015. Epub 2014 Feb 19.

PMID:
24554524
5.

Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators.

Seegers J, Conen D, Jung K, Bergau L, Dorenkamp M, Lüthje L, Sohns C, Sossalla ST, Fischer TH, Hasenfuss G, Friede T, Zabel M.

Europace. 2016 Aug;18(8):1194-202. doi: 10.1093/europace/euv361. Epub 2015 Nov 29.

6.

Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.

Blumer J, Wolber T, Hellermann J, Holzmeister J, Binggeli C, Duru F, Brunckhorst C.

Int Heart J. 2009 May;50(3):313-21.

7.
8.

Greater mortality risk among patients with delayed follow-up after implantable cardioverter defibrillator procedures.

Laksman ZW, Krahn AD, Dorian P, Simpson CS, Crystal E, Healey JS, Khaykin Y, Wang X, Lee DS.

Can J Cardiol. 2014 Jun;30(6):598-605. doi: 10.1016/j.cjca.2014.03.028. Epub 2014 Mar 27.

PMID:
24882529
9.

The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.

Bhavnani SP, Pavuluri V, Coleman CI, Guertin D, Yarlagadda RK, Clyne CA, Kluger J.

Pacing Clin Electrophysiol. 2013 Jul;36(7):878-84. doi: 10.1111/pace.12141. Epub 2013 Apr 24.

PMID:
23614760
10.

Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients.

van der Heijden AC, Thijssen J, Borleffs CJ, van Rees JB, Höke U, van der Velde ET, van Erven L, Schalij MJ.

Heart. 2013 Sep;99(17):1244-9. doi: 10.1136/heartjnl-2013-304013. Epub 2013 May 30.

PMID:
23723448
11.

Summaries for patients: Implantable cardioverter-defibrillators in women.

[No authors listed]

Ann Intern Med. 2012 Feb 7;156(3):I30. doi: 10.7326/0003-4819-156-3-201202070-00002. No abstract available.

PMID:
22312155
12.
13.

Survival after implantable cardioverter-defibrillator implantation in the elderly.

Yung D, Birnie D, Dorian P, Healey JS, Simpson CS, Crystal E, Krahn AD, Khaykin Y, Cameron D, Chen Z, Lee DS.

Circulation. 2013 Jun 18;127(24):2383-92. doi: 10.1161/CIRCULATIONAHA.113.001442.

14.

Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?

Koyak Z, de Groot JR, Van Gelder IC, Bouma BJ, van Dessel PF, Budts W, van Erven L, van Dijk AP, Wilde AA, Pieper PG, Sieswerda GT, Mulder BJ.

Circ Arrhythm Electrophysiol. 2012 Feb;5(1):101-10. doi: 10.1161/CIRCEP.111.966754. Epub 2011 Nov 17.

15.

Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women-Data From a Multicenter French Registry.

Providência R, Marijon E, Lambiase PD, Bouzeman A, Defaye P, Klug D, Amet D, Perier MC, Gras D, Algalarrondo V, Deharo JC, Leclercq C, Fauchier L, Babuty D, Bordachar P, Sadoul N, Piot O, Boveda S.

J Am Heart Assoc. 2016 Feb 12;5(2). pii: e002756. doi: 10.1161/JAHA.115.002756.

16.

Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.

Goldenberg I, Moss AJ, Hall WJ, McNitt S, Zareba W, Andrews ML, Cannom DS; Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Investigators.

Circulation. 2006 Jun 20;113(24):2810-7. Epub 2006 Jun 12.

17.

Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications.

Vriesendorp PA, Schinkel AF, Van Cleemput J, Willems R, Jordaens LJ, Theuns DA, van Slegtenhorst MA, de Ravel TJ, ten Cate FJ, Michels M.

Am Heart J. 2013 Sep;166(3):496-502. doi: 10.1016/j.ahj.2013.06.009. Epub 2013 Jul 16.

PMID:
24016499
18.

Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.

Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC Jr, Brieke A, Sauer WH.

J Heart Lung Transplant. 2010 Jul;29(7):771-6. doi: 10.1016/j.healun.2010.02.001. Epub 2010 Mar 29.

PMID:
20347337
19.

Evaluating sex differences in population-based utilization of implantable cardioverter-defibrillators: role of cardiac conditions and noncardiac comorbidities.

MacFadden DR, Tu JV, Chong A, Austin PC, Lee DS.

Heart Rhythm. 2009 Sep;6(9):1289-96. doi: 10.1016/j.hrthm.2009.05.017. Epub 2009 May 18.

PMID:
19695966
20.

The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy.

O'Mahony C, Lambiase PD, Quarta G, Cardona M, Calcagnino M, Tsovolas K, Al-Shaikh S, Rahman SM, Arnous S, Jones S, McKenna W, Elliott P.

Heart. 2012 Jan;98(2):116-25. doi: 10.1136/hrt.2010.217182. Epub 2011 Jul 13.

PMID:
21757459

Supplemental Content

Support Center